Cervical Imaging Device Prompts FDA Panel Concern With False Positives
This article was originally published in The Gray Sheet
Executive Summary
FDA's Obstetrics & Gynecology Devices Panel concluded May 17 that MediSpectra's pivotal studies failed to show a statistically significant benefit for the Luma cervical imager